维普期刊资源整合服务平台（V6.5）

361篇 您的检索式：作者名="Rowinsky"

选中清除导出查看参考文献查看引证文献引用追踪共19页首页上一页第1页下一页末页 /19 跳转

	题名	作者	年代	出处	被引量
1	Phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of AP23573, an mTOR inhibitor, administered Ⅳ daily X 5 every other week in patients (pts) with refractory or advanced malignanciSs显示文摘	Mita MM Rowinsky EK Goldston ML	2004	Clin Oncol2004，30，3：	1
2	Taxol:a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms显示文摘	McGuire WP Rowinsky EK Rosenshein NB	1989	Ann Intern Med1989，111，4：	1
3	The ErbB receptor family:a therapeutic target for cancer显示文摘	DEBONO J S ROWINSKY E K	2002	Trends Mol Med2002，8，：	1
4	Neurotoxicity of taxol显示文摘	Rowinsky EK Chaudhry V Cornblath DR	1993	J Natl Cancer Inst Monogr1993，15，：	1
5	A reassessment of cardiac toxicity associated with Taxol 显示文摘	Arbuck SG Strauss H Rowinsky E	1997	J Natl Cancer lnst Monogr1997，2，15：	1
6	The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents 显示文摘	Rowinsky E K	2000	Drugs2000，60，1：	1
7	Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody显示文摘	Kenneth A Foon Xiao-Dong Yang Louis M Weiner Arie S Belldegrun Robert A Figlin Jeffrey Crawford Eric K Rowinsky Janice P Dutcher Nicholas J Vogelzang Jared Gollub John A Thompson Garry Schwartz Ronald M Bukowski Lorin K Roskos Gisela M Schwab	2004	International Journal of Radiation Oncology Biology Physics2004，，3：	1
8	The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents 显示文摘	Rowinsky EK	2000	Drugs2000，60，1：	1
9	Paclitaxel in cancer treatment显示文摘	McGuire WP Rowinsky EK	1995	Marcel Dekker Inc USA1995，3540，：	1
10	Phase Ⅰ and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory aucte leukemia显示文摘	Rowinsky EK Adjiei R Donehower RC	1994	J Clin Oncol1994，12，：	1
11	Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI -774 in human epidermis of cancer patients 显示文摘	Malik SN Siu LL Rowinsky EK	2003	Clin Cancer Res2003，9，：	1
12	Targeted induction of apoptosis in cancer management:the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents显示文摘	Rowinsky E K	2005	J Clin Oncol2005，23，36：	1
13	kappa-Opioid agonist modulation of [3H]thymidine incorporation into DNA:evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover显示文摘	BARG J BELCHEVA M M ROWINSKI J		0，，04：	1
14	Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors 显示文摘	Rowinsky E K	2002	Cancer Invest2002，20，3：	1
15	Paclitaxel (Taxol) 显示文摘	ROWINSKY R K DONEHOWER R C	1995	N Engl J Med1995，332，：	1
16	Properties of the dead zone model of longitudinal dispersion in rivers显示文摘	CZERNUSZENKO W ROWINSKI P M	1997	J Hydraulic Res1997，35，4：	1
17	The current status of comptothecin analogs as antitumor agonts显示文摘	Slichenmger W J Rowinsky E K Donehouer R C	1993	J Natl Cancer Iust1993，85，：	1
18	Vascular endothelial growth factor receptor-1 in human cancer:concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1)显示文摘	Schwartz JD Rowinsky EK Youssoufian H		0，，：	1
19	A reassessment of cardiac toxicity associated with taxol显示文摘	Arbuck S G Strauss H Rowinsky E	1993	J Natl Cancer Inst Monogr1993，，15：	1
20	Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms 显示文摘	MCGUIRE WP ROWINSKY EK ROSENSHEIN NB	1989	Annals of Internal Medicine1989，111，4：	1

返回顶部每页显示：

共19页首页上一页第1页下一页末页 /19 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示